País: Australia
Idioma: inglés
Fuente: Department of Health (Therapeutic Goods Administration)
nicotine polacrilex, Quantity: 10 mg
Johnson & Johnson Pacific Pty Ltd
Nicotine polacrilex
Gum, chewing
Excipient Ingredients: titanium dioxide; light magnesium oxide; sodium carbonate; hypromellose; xylitol; menthol; sucralose; Carnauba Wax; acesulfame potassium; sodium bicarbonate; Acacia; Peppermint Oil; polysorbate 80; calcium carbonate; butylated hydroxytoluene; isobutylene/isoprene copolymer; polyisobutylene; polyethylene; polyvinyl acetate; synthetic terpene resin; microcrystalline wax; mono- and di- glycerides; Flavour
Buccal
315, 105, 310, 30, 15, 255, 370, 400, 75, 210, 150, 240, 270, 385, 300, 355, 225, 340, 325, 285, 200, 180
Not scheduled. Not considered by committee
For the treatment of tobacco dependence by relieving nicotine craving and withdrawal symptoms, thereby facilitaing smoking cessation in smokers motivated to quit. In smokers unable or not ready to stop smoking abruptly, the inhaler or gum may also be used as part of a smoking reduction strategy as a step towards stopping completely.
Visual Identification: Square, coated, light beige coloured piece of gum with a minty odour.; Container Type: Blister Pack; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2007-07-24